News

Same-Day HIV Treatment Improves Health Outcomes

The results of a clinical trial, run by Boston University with support from HE2RO, show that same-day initiation of antiretroviral therapy (ART) for HIV patients in South Africa led to a higher proportion of people starting treatment and to better health outcomes. The study was led by Sydney Rosen, a BU Research Professor and Director of HE2RO. A short video and further information can be seen 

Presentation at the Southern African HIV Clinicians Society Conference

Mr Lawrence Long and Dr Sophie Pascoe will be presenting at a session on using routine data to inform evidence based policy on 14th April 2016 at the Southern African HIV Clinicians Society Conference in Sandton, Johannesburg. Please see the attached flyer for further 

Launch of the Phase 1 South African HIV and TB Investment Case

On Mar 22, 2016 the reports for Phase 1 of the South African HIV and TB Investment Case were launched by the Deputy President during the World TB Day celebrations. HE2RO staff were heavily involved in all aspects of the development of the Investment Case, from devising the analytical framework to reviewing evidence for interventions and enablers to developing the novel optimisation method driving the model analysis to writing the reports. The reports are available for download in full (SA 

Carte Blanche Feature on PrEP

Gesine Meyer-Rath was interviewed by the Carte Blanche team, who were interested on doing a feature on PrEP. Please find a link below to view the interview. Carte Blanche Feature 

Welcoming New Staff

HE2RO would like to welcome Patience Manjengwa as a Researcher and Nelly Jinga as A Research Associate in Epidemiology, as well as Sharon Kgowedi as a Research Associate Health 

HE2RO Presenting at CROI 2016

A selection of HE2RO staff are attending CROI 2016 in Boston US, from 22nd to 25th February 2016. HE2RO staff are presenting a number of poster presentations, and oral presentations.  For further information please see CROI 2016 

HE2RO Presenting at TB Union

Two of HE2RO's staff will be presenting at the 46th Union World Conference on Lung Health, in Cape Town from 2nd to 6th December 2015. Kamban Hirasen will be presenting on: "Twelve month outcomes of patients initiating drug-resistant tuberculosis treatment at a decentralised outpatient clinic in Johannesburg, South Africa". Denise Evans will be presenting on: "Predictors of mortality in patients diagnosed with preXDR and XDR TB - Results from the South African National TB Programme 2009 

HE2RO at SAMEA

HE2RO Research Fellow, Tembeka Sineke, presented on “Social and Behavioral factors associated with failing second-line ART, Results from a cohort study at the Themba Lethu Clinic, Johannesburg, South Africa” at SAMEA, in Sandton, Johannesburg from 12th to 16th October 

Welcoming New Staff

HE2RO would like to welcome Amy Huber as a Researcher, Joshua Murphy as Research Project Manager, Nokhwezi Mabutyana (Ekurhuleni), Tebogo Mampheko (Limpopo), Mishak Masingi (North West), and Nomzama Mvandaba (Kwazulu-Natal) as Provincial Study Co-Ordiantors  on a new project entiitled "Evaluation of the National Department of Health's National Adherence Guidelines for Chronic Diseases in South Africa Using Routinely Collected 

HE2RO’s at SA AIDS

A selection of HE2RO staff will be attending SA AIDS in Durban from 9th to 12th June 2015. HE2RO will have a stand at the conference and HE2RO staff are presenting 6 poster presentations, 2 oral presentations, are on the panel of 2 round tables and two satellite sessions. For further information please see HE2RO Presentations at SA AIDS, the SA AIDS program or come to the HE2RO stand and speak to one of our 

HE2RO wins NIH Funding

HE2RO has been awarded a five year grant from the National Institutes of Health to fund a new project; Analysis of National Lab Database to evaluate the HIV treatment rollout in South Africa. Congratulations to the PI, Dr Mhairi Maskew for winning this 

Stay up to date

Receive newsletters and keep up to date with developments at HE2RO.